LLLT Could Lead To Aggravations In Skin Cancer

High beam radiations of LLLT or low-level laser therapy must ideally not be employed over melanomas. Researchers that have written in the open access journal BMC Cancer evaluated the pain and inflammation allaying ‘cold laser’ and found that it lead to heightened tumour development in a mouse model of skin cancer.

Jan M. Bjordal at the University College in Norway teamed up with some Brazilian researchers for conducting in vitro and in vivo researches. He stated that LLLT has garnered immense recognition for treating soft tissue damage and joint conditions. But, there is a dearth of proof, particularly in vivo proof, regarding the outcome of LLLT in malignant conditions like melanoma.

Bjordal and his associates implemented LLT on cancer cultures and on mice that were infused with melanoma cells. The treatment though did not lead to any major alterations in the cell cultures, directly irradiating the tumor using high dosage LLT lead to considerable surge in tumor mass quantity and major histological variations, suggesting a deterioration of the cancer among mice. The researchers wrote that elevated irradiance (about 2.5W/sq.cm) merged with elevated dosage of 1050 J/sq.cm could fuel melanoma tumor growth with diverse histological traits in vivo.

Bjordal further mentioned that it was imperative that there is implementation of this contraindication into clinical practice so that LLLT could stay a harmless treatment option.

LLLT was initiated in the 1970s, when it was found that light emitted from low-strength lasers could cause increased cell proliferation. It is promoted for treating hair loss, managing pain, sports medication and skin care treatments – amongst several other items. Self-help home based treatments are obtainable online.

Popularity: 16% [?]